arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CONSTELLIUM SE

CSTM

$29.47 ▲ +0.87 (+3.04%) at close

4 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

CONSTELLIUM SE shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $4.1B

Dividend Yield —

Revenue Growth 15.2% ↗

Op. Margin —

ROIC —

FCF / Share $1.14 ↗

Trailing P/E 15.1x

Price / Book 4.2x

FCF Yield 3.9%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$8.45B

↑ +15.2% —

Net Income Profit after all expenses

$273.00M

↑ +387.5% —

FCF / Share Free cash flow per share

$1.14

↑ +248.1% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability →

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	15.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+204%)	-6.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-225%)	-8.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-265%)	—
EPS Growth YoY (%)	413.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-63.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-51.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	387.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-63.2% Weak Weak Year-over-year change in net income	-50.6% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	N/M	N/M	-14.6% Weak Weak Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	-0.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—
EPS CAGR 3Y (%)	-3.1% Weak Weak Compound annual EPS growth over 3 years	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Effective Tax Rate (%) (%)	32.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	55.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	32.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-110.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	3.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-60%)	0.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-90%)	1.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-76%)	3.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)
FCF Margin (%) (%)	1.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	0.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	0.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.58x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Common Equity (%) (%)	28.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+139%)	7.9% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	21.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+76%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Net Debt (USD)	$-120.00M	$-141.00M	$-223.00M	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$60.49	$50.34	$53.56	$59.40
Basic EPS, GAAP (USD)	$1.95	$0.38	$1.04	$2.14
Free Cash Flow per Share (USD)	$1.14	$-0.77	$0.45	$0.53
Book Value per Share (USD)	$7.03	$4.92	$4.91	—
Tangible Book Value per Share (USD)	$6.68	$4.60	$4.63	—
Basic Weighted Avg Shares (shares)	139.68M	145.72M	146.13M	143.63M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$524.00M	$388.00M	$436.00M	—
Total Equity (USD)	$952.00M	$706.00M	$718.00M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$8.45B	$7.33B	$7.83B	$8.53B
Depreciation Expense (USD)	$330.00M	$304.00M	$300.00M	$290.00M
Net Income, GAAP (USD)	$273.00M	$56.00M	$152.00M	$308.00M
Operating Cash Flow (USD)	$489.00M	$301.00M	$432.00M	$365.00M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 10 quarters

CONSTELLIUM SE

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CSTM with peers